In addition, high levels of HSF1 in ERα-positive breast cancers are associated with poor prognosis for patients treated with tamoxifen (Santagata et al, 2011; Mendillo et al, 2012; Gökmen-Polar & Badve, 2016). The gene discussed is HSF1; the disease is breast cancer.